[1] Goldring S R,Goldring M B.Clinical aspects, pathology and pathophysiology of osteoarthritis[J]. musculoskeletal & neuronal inter,2006,10(6):376-378.
[2] Sun J, Gooch K, Svenson LW, et al. Estimating osteoarthritis incidence from population-based administrative health care databases[J]. Annals of epidemiology,2007, 17(1): 51-56.
[3] 李宁华 . 中老年人群骨关节炎的流行病学特征 [J]. 中国临床康复 , 2005, 9(38):133-135.
[4] Kroenke K,Wu J,Bair M J,et al. reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care[J].Pain,2011,12 (9):964-973
[5] Arnold L M, Lu Y, Crofford L J, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of bromyalgia patients with or without major depressive disorder[J].Arthritis and rheumatism, 2004, 50(9): 2974-2984.
[6] Goldstein D J, Lu Y, Detke M J, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy[J].Pain, 2005, 116(1-2):109-118.
[7] Lie H C,Hiermstad M J,Fayers P,et al.Depression in advanced cancer-assessment challenges and associations with disease load[J].J Affect Disord,2015,173:176-184.
[8] Felson D T, Lawrence R C, Dierre P A, et al. Osteoarthritis new insights Part 1:the disease and its risk factors[J].Am Intem Med,2000,133:635- 646.
[9] Avluk O C,Gurcay E,Gurcay A G,et al.Effects of chronic pain on function,depression,and sleep among patients with traumatic spinal cord injury[J].Ann Sandi Med,2014,34(3):211-216.
[10] Mc Alindon T E,Bannuru R R,Sullivan M C,et al.OARSI guidelines for the nonsurgical management of knee osteoarthritis.Osteoarthritis and cartilage/OARS[J].Osteoarthritis Research Society,2014,22(3):363-388.
[11] 陈均源,李劼若,罗斯敏,等.度洛西汀治疗骨关节炎慢性疼痛的研究进展[J].中国疼痛医学杂志,2016,22(7):56-58
[12] 刘东波,李淑英,崔 鹤,等.细胞色素P450酶1A2基因多态性与度洛西汀抗抑郁临床疗效的关系[J].中华行为医学与脑科学杂志,2014,32(2):144-147.